Brexpiprazole - Lundbeck/Otsuka
At a glance
- Drug Originator Otsuka Pharmaceutical Development & Commercialization
- Drug Licenced by Lundbeck A/S
- Drug Class Antidepressants; Antipsychotics; Behavioural disorder therapies; Piperazines; Quinolines; Sleep disorder therapies; Small molecules; Thiophenes
- Mechanism of Action Dopamine D2 receptor partial agonists; Serotonin 1A receptor partial agonists; Serotonin 2A receptor antagonists
- USA Patent Applicants OTSUKA
- USA Patents 8
- NDAs 1
- International Patents 73
- Patent Applications 319
Table of Contents

Disclaimer